Comunicados de prensa de Smart Sand

NEW YORK, Oct. 30, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that Michael A. M…

NEW YORK, Oct. 15, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that Revuforj ® (…

EDMONTON, Alberta, Oct. 14, 2026 (GLOBE NEWSWIRE) -- SNDL Inc. (NASDAQ: SNDL, CSE: SNDL) (" SNDL ") announced today that it will release its third quarter 2026 financial results for the period ended S…

EDMONTON, Alberta, Oct. 06, 2026 (GLOBE NEWSWIRE) -- SNDL Inc. (NASDAQ: SNDL, CSE: SNDL) (“ SNDL ” or the “ Company ”) announced today that Carlo Cannell has resigned from the Board of Directors effec…

YARDLEY, Pa., Sept. 15, 2026 /PRNewswire/ -- Smart Sand, Inc. (NASDAQ: SND) ("Smart Sand" or the "Company") announced today that it will participate in a webcast presentation and host one-on-one meeti…

도쿄 및 밀피타스, 캘리포니아--(Business Wire/뉴스와이어)--키오시아 홀딩스(Kioxia Holdings Corporation, TOKYO: 285A)의 자회사인 키오시아 코퍼레이션 (Kioxia Corporation)과 샌디스크 코퍼레이션(Sandisk Corporation, NASDAQ: SNDK)은 오늘 정부 지원을 전...

NEW YORK, July 28, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that it will repo…

EDMONTON, Alberta, July 27, 2026 (GLOBE NEWSWIRE) -- SNDL Inc. (NASDAQ: SNDL, CSE: SNDL) ( “SNDL ” or the “ Company ”) today announced the completion of the acquisition of certain assets of Surterra H…

YARDLEY, Pa., July 16, 2026 /PRNewswire/ -- Smart Sand, Inc. (NASDAQ: SND) ("Smart Sand" or the "Company") announced today that its board of directors has declared a special cash dividend on the Compa…

EDMONTON, Alberta, July 15, 2026 (GLOBE NEWSWIRE) -- SNDL Inc. (NASDAQ: SNDL, CSE: SNDL) (" SNDL ") announced today that it will release its second quarter 2026 financial results for the period ended…

NEW YORK, June 04, 2026 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals, Inc. (“Syndax”) (NASDAQ: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, has entered into…

EDMONTON, Alberta, May 27, 2026 (GLOBE NEWSWIRE) -- SNDL Inc. (Nasdaq: SNDL, CSE: SNDL) (“ SNDL ”) announces that the transaction relating to the acquisition of the remaining 1CM Inc. (“ 1CM ”) Ontari…